Title:
ＮＫ−１受容体アンタゴニストを含むエマルジョン
Document Type and Number:
Japanese Patent JP6829257
Kind Code:
B2
Abstract:
Disclosed herein are novel pharmaceutical formulations of a neurokinin-1 (NK-1) receptor antagonist suitable for parenteral administration including intravenous administration. Also included are formulations including both the NK-1 receptor antagonist and dexamethasone sodium phosphate. The pharmaceutical formulations are stable oil-in-water emulsions for non-oral treatment of emesis and are particularly useful for treatment of subjects undergoing highly emetogenic cancer chemotherapy.
Inventors:
Ottboni, Thomas Bee.
Han, Han
Han, Han
Application Number:
JP2018539883A
Publication Date:
February 10, 2021
Filing Date:
February 01, 2016
Export Citation:
Assignee:
Heron Therapeutics, Inc.
International Classes:
A61K31/5377; A61K9/107; A61K31/438; A61K31/573; A61K47/10; A61K47/12; A61K47/26; A61K47/44; A61P1/08; A61P43/00
Domestic Patent References:
| JP2013501806A | ||||
| JP2017533183A |
Foreign References:
| CN102379845A |
Attorney, Agent or Firm:
Takeshi Oshio